Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 1, 2010, Pages 49-58

  Nielsen, M J ^a   Norgaard M ^a   Holland Fisher, P ^a   Christensen, L A ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; CIPROFLOXACIN; GLUCOCORTICOID; MESALAZINE; METRONIDAZOLE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SMOKING; VALIDITY;

ADULT; CROHN DISEASE; DENMARK; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 77953191004     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04318.x     Document Type: Article

References (43)

1. Jacobsen BA, Fallingborg J, Rasmussen HH, et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 2006 18 : 601 606.
2. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004 15 : 237 241.
3. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002 97 : 641 648.
4. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005 100 : 102 105.
5. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000 342 : 1627 1632.
6. Feagan BG, Enns R, Fedorak RN, et al. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics. Can J Clin Pharmacol 2001 8 : 188 198.
7. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med 1994 331 : 836 841.
8. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996 110 : 45 51.
9. Kane S. Patient compliance and outcomes. Inflamm Bowel Dis 1999 5 : 134 137.
10. Steinhart H. Maintenance therapy in Crohn's disease. Can J Gastroenterol 2000 14 (Suppl C 23C 8C.
11. Haynes RB, Sackett DL, Taylor DW. How to detect and manage low patient compliance in chronic illness. Geriatrics 1980 35 : 91 7.
12. Farup PG, Hovde O, Halvorsen FA, et al. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995 30 : 164 170.
13. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001 96 : 2929 2933.
14. Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990 31 : 179 183. (Pubitemid 20092152)
15. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982 4 : 333 336.
16. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003 114 : 39 43.
17. Nigro G, Angelini G, Grosso SB, et al. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol 2001 32 : 66 8.
18. Vohr BR, Tyson JE, Wright LL, et al. Maternal age, multiple birth, and extremely low birth weight infants. J Pediatr 2009 154 : 498 503.
19. Klassifikation af Sygdomme, 10. revision 1. udgave (International Classification of Disease, 10th rev. 1st. ed)
20. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998 45 : 320 323.
21. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007 102 : 1417 1426.
22. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci 2008 53 : 1020 1024.
23. D'Inca R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008 27 : 166 172.
24. Norgard B, Fonager K, Pedersen L, et al. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003 52 : 243 247.
25. Wisborg K, Henriksen TB, Hedegaard M, Secher NJ. Smoking habits among Danish pregnant women from 1989 to 1996 in relation to sociodemographic and lifestyle factors. Acta Obstet Gynecol Scand 1998 77 : 836 840.
26. Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther 2005 21 : 509 513.
27. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000 95 : 1021 1026.
28. Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009 15 : 1233 1239.
29. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996 110 : 424 431.
30. Thomas GA, Rhodes J, Green JT, Richardson C. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 2000 76 : 273 279.
31. Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease Am J Gastroenterol 2006 101 : 1539 1545.
32. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006 55 (Suppl 1 i16 35.
33. Liu H, Kaplan AH, Wenger NS. Measuring patient adherence. Ann Intern Med 2002 1 : 72 3.
34. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980 2 : 757 764.
35. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999 37 : 846 857.
36. DiMatteo MR, Hays RD, Sherbourne CD. Adherence to cancer regimens: implications for treating the older patient. Oncology (Williston Park) 1992 6 (2 Suppl 50 7.
37. Horne R, Parham R, Driscoll R, Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009 15 : 837 844.
38. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007 13 : 591 599.
39. Mountifield R, Bampton P, Prosser R, et al. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009 15 : 720 725.
40. Fonager K, Sorensen HT, Rasmussen SN, et al. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol 1996 31 : 154 159.
41. Kristensen J, Langhoff-Roos J, Skovgaard LT, Kristensen FB. Validation of the Danish Birth Registration. J Clin Epidemiol 1996 49 : 893 897.
42. Knudsen LB. Paritetsoplysningen i Sundhedsstyrelsens medicinske fødselsregister Information on parity in the medical registry of births of the National Board of Health). 1993.
43. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003 98 : 1535 1544.